ED
MTZ icon

Exane Derivatives’s MasTec MTZ Stock Holding History

Exane Derivatives’s Portfolio MTZ Stock Details MTZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$183K Sell
2,557
-695
-21% -$54.2K 0.11% 184
2022
Q1 		$283K Sell
3,252
-584
-15% -$51K 0.08% 256
2021
Q4 		$354K Sell
3,836
-61
-2% -$5.58K 0.09% 232
2021
Q3 		$336K Sell
3,897
-3,240
-45% -$307K 0.08% 257
2021
Q2 		$740K Buy
7,137
+5,980
+517% +$649K 0.17% 120
2021
Q1 		$108K Buy
1,157
+224
+24% +$19.2K 0.03% 413
2020
Q4 		$63.6K Buy
933
+375
+67% +$21K 0.02% 441
2020
Q3 		$23.5K Buy
+558
New +$24K 0.01% 427

Other funds holding MTZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $1.07B AUM 26.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's MTZ Position: Q2 2022 in Review

Exane Derivatives reduced its MasTec (MTZ) stake by 21% in Q2 2022, selling an estimated $54.2K and leaving 2,557 shares worth $183K. The position accounts for 0.11% of the portfolio, ranked #184.

Exane Derivatives first reported a position in MTZ in Q3 2020 and has held it in 8 quarters since. The position peaked at $740K in Q2 2021. 355 funds tracked by Wall St. Rank hold MTZ as of Q2 2022.

  • Exane Derivatives held 2,557 shares of MasTec worth $183K as of Q2 2022.
  • Exane Derivatives sold 695 MasTec shares in Q2 2022, an estimated $54.2K.
  • MasTec made up 0.11% of Exane Derivatives's portfolio in Q2 2022, its #184 holding.
  • Exane Derivatives first reported a position in MasTec in Q3 2020 and has held it in 8 quarters since.
  • Exane Derivatives's MasTec position peaked at $740K in Q2 2021.
  • 355 funds tracked by Wall St. Rank held MasTec as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.